Introduction {#s1}
============

Tic disorders (TDs) are neurodevelopmental diseases characterized by fast, sudden, non-rhythmic, repetitive, and stereotyped phonic production and/or movements ([@B1]). Over two-thirds of individuals with TDs experience improvement in late adolescence, but some continue to have severe tics and need intensive treatment in adulthood ([@B2]). TDs are frequently comorbid with other conditions such as attention-deficit/hyperactivity disorder, obsessive--compulsive disorder, anxiety disorder, depression, and "rage attacks" (sudden, explosive episodes of rage) ([@B3]--[@B5]). A previous epidemiological study found that the prevalence was 2.99% for transient tic disorder, 1.615% for chronic tic disorder, and 0.77% for Tourette syndrome ([@B6]).

Caregivers of patients with TDs have been reported as having a tendency to develop psychological diseases ([@B7]). Both children and caregivers emphasize the importance of reducing tics, so appropriate treatment is a clinical priority.

Treatment approaches to TDs vary considerably with the severity and complexity of the clinical picture. Motor/vocal tics and comorbid symptoms are often managed by pharmacotherapy. The most common pharmacological treatments include antipsychotics, alpha-2 adrenoreceptor agonists, and antiepileptic drugs. Successful therapy for TDs can eliminate or reduce symptoms, so adherence to medication is important for treatment success. Adherence to medication is defined as the extent to which a person\'s behavior in taking medication corresponds with the agreed recommendation from a healthcare provider ([@B8]).

Adherence to treatment remains important for successful TD management. However, no studies had previously assessed adherence or the factors that affect it in children with TDs. This study, therefore, aimed to (1) assess adherence rates for children with TDs from western China and (2) identify factors (e.g., basic characteristics, disease status, medication status, and family situation) associated with non-adherence.

Methods {#s2}
=======

Study Design
------------

This was a cross-sectional study using a questionnaire to assess adherence to prescribed medication for TDs in children. Based on the published literature and expert opinions, a questionnaire was designed by investigators to collect data in person. A pre-tested structured questionnaire was then administered by a trained pharmacist or doctor. Data were collected by investigators during face-to-face interviews lasting 15--20 min.

Study Population
----------------

Eligible patients were consecutively selected by the physicians, who informed them of the study objectives and recruited all patients from the Pediatric Neurology clinic who agreed to participate between January and May 2019. The study was carried out in West China Second Hospital of Sichuan University (Sichuan Province, China). The hospital is the largest and most authoritative center for the diagnosis and treatment of childhood diseases in western China. It currently holds 1,580 beds and covers two districts. The hospital performs a large amount of clinical work, such as treatment, referral, and consultation for children with critical illnesses.

The inclusion criteria were: (1) a clinically confirmed diagnosis of TD, (2) the patient\'s written informed consent, and (3) age \< 18 years. The exclusion criteria were: (1) delays or problems with mental development (Wechsler intelligence quotient \[IQ\] scores \< 70 points), (2) presence of other chronic diseases (e.g., congenital heart disease, diabetes) that could affect adherence to therapeutic guidelines, and (3) lack of consent.

Data Collection
---------------

A specifically-designed questionnaire was used to collect data. Children over 8 years old completed the questionnaire independently, and those under 8 years old were assisted by their guardians. The questionnaire covered four aspects, details of which are shown in [Table 1](#T1){ref-type="table"}.

###### 

The five aspects of the designed questionnaire.

  **Aspects**              **Variable**
  ------------------------ -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Basic characteristics:   Name, gender, age
  Disease status:          Time of disease, type of visit to the hospital, tic symptom, type of TD, family history, comorbidity, quality of life, regular review
  Medication status        Type of medication, quantity of medication, beliefs about the necessity of taking medication, any concerns about taking medication
  Family situation:        Parents\' marital status, caregiver\'s relationship with child, caregiver\'s age, education level, place of residence, total household income, and medical expenses payment

Instruments
-----------

Two validated instruments were used: the Beliefs about Medicines Questionnaire (BMQ) and the eight-item Morisky Medication Adherence Scale (MMAS-8).

### Beliefs About Medicines Questionnaire (BMQ)

The BMQ was used to assess patients\' beliefs about the medication prescribed for a particular illness. It is divided into two major subscales: "Necessity Beliefs" and "Concerns." The Necessity Beliefs subscale assesses the patients\' views on the necessity of taking the medication to maintain or improve their health. The Concerns subscale focuses on beliefs about the adverse effects of taking medication ([@B9]). Total scores for both subscales range from 5 to 25. Higher scores indicate stronger beliefs.

### Medication Adherence

The Morisky Medication Adherence Scale (MMAS-8) was used to assess patients\' medication adherence. This scale is widely used and has good reliability and validity ([@B10], [@B11]). MMAS-8 consists of eight questions with a scoring scheme of "Yes" = 0 and "No" = 1, and the items are summed to give a range of scores from 0 to 8. Higher scores indicate better adherence. This self-report measure is reported to have acceptable internal consistency and has demonstrated construct validity ([@B12]). Each item measures a specific medication-taking behavior, and the aggregate score indicates patients\' inclination to adhere to their prescribed medication. Scores of 8 were considered to show high adherence, scores of 6--7 medium, and scores of 0--5 low ([@B12]). We attended a training and certification session for the Morisky Widget in August 2019 in Beijing, China, and obtained licenses for the use of MMAS-8 from MMAS Research LLC, USA.

Data Analysis
-------------

The differences between adherent and non-adherent groups were investigated using analysis of variance for continuous variables. Quantitative variables are shown as mean and standard deviation, and qualitative variables as frequency and percentage. Categorical variables were analyzed using the chi-square or Fisher\'s exact test as appropriate. Quantitative variables were analyzed using variance analysis.

Following the univariate analysis, factors with *p* ≤ 0.05 were included in the multivariate logistic regression model. Multivariate analysis was used to examine the relative contribution of potential predictors of adherence categorization using ordered logistic regression. A *p* ≤ 0.05 was assumed to be statistically significant. Data analysis used SPSS version 22 (SPSS Inc., Chicago, IL, USA).

Ethical Issues
--------------

The study was approved by the Office of Research Ethics Committees of West China Second Hospital. Written informed consent was obtained from all caregivers, and consent was obtained from children aged \>8 years.

Results {#s3}
=======

Basic Characteristics
---------------------

In total, 212 patients were clinically examined during the study period, of whom six refused to participate in the study and two showed mental development issues, giving a total of 204 patients (96.2%) who fulfilled the inclusion criteria.

Of these, 77.5% (158/204) were male, aged 7.69 ± 2.58 years, 37.7% (77/204) were newly diagnosed, 46.1% (94/204) were review patients, and 16.2% (33/204) were recurrent patients. Over half, 55.9% (114/204), only had motor tic symptoms, 5.9% (12/204) showed vocal tic symptoms, and 38.2% (78/204) showed both. In total, 45.1% (92/204) children had transient tic disorder, 31.9% (65/204) chronic tic disorder, and 23.0% (47/204) Tourette syndrome, while 9.8% (20/204) had a family history of TDs, and 18.1% (37/204) had comorbidities. The characteristics of the participants are shown in [Table 2](#T2){ref-type="table"}.

###### 

Characteristics of the study population.

  ----------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                     **Low adherence**   **Medium adherence**   **High adherence**   **χ^2^ /F**   ***P***
  --------------------------------- -------------------------------- ------------------- ---------------------- -------------------- ------------- ---------
  **Gender**                                                                                                                                       

                                    Male                             54                  38                     66                   0.790         0.674

                                    Female                           19                  10                     17                                 

  Age                                                                7.57 ± 2.30         8.48 ± 2.93            7.35 ± 2.54          3.066         0.049

  Time of disease                   1.15 ± 1.11                      1.75 ± 1.47         1.40 ± 1.38            2.724                0.068         

  **Type of visiting**                                                                                                                             

                                    New diagnosis                    29                  15                     33                   4.207         0.379

                                    Review                           30                  28                     36                                 

                                    Relapse                          14                  5                      14                                 

  **Tic symptom**                                                                                                                                  

                                    Motor tic                        41                  26                     47                   1.508         0.825

                                    Vocal tic                        5                   4                      3                                  

                                    Both                             27                  18                     33                                 

  **Type of TDs**                                                                                                                                  

                                    TTD                              36                  17                     39                   3.337         0.503

                                    CTD                              23                  16                     26                                 

                                    TS                               14                  15                     18                                 

  **Family history**                                                                                                                               

                                    No                               67                  46                     71                   3.965         0.138

                                    Yes                              6                   2                      12                                 

  **Comorbidity**                                                                                                                                  

                                    No                               62                  37                     68                   1.202         0.548

                                    Yes                              11                  11                     15                                 

  Quality of life                   80.69 ± 11.99                    79.98 ± 12.03       85.31 ± 10.39          4.615                0.011         

  **Regular review**                                                                                                                               

                                    No                               5                   4                      3                    1.469         0.480

                                    Yes                              68                  44                     80                                 

  **Type of medication**                                                                                                                           

                                    Tiapride                         30                  27                     35                   13.915        0.177

                                    Clonidine                        7                   1                      6                                  

                                    Vitamins                         18                  10                     21                                 

                                    Tiapride+Clonidine\              16                  8                      18                                 
                                    +Vitamins                                                                                                      

                                    Tiapride+Clonidine\              2                   0                      3                                  
                                    +Haloperidol                                                                                                   

                                    Tiapride+Clonidine +Topiramate   0                   2                      0                                  

  **Quantity of medication**                                                                                                                       

                                    1                                55                  38                     62                   0.358         0.836

                                    ≥2                               18                  10                     21                                 

  Necessity beliefs                 3.03 ± 0.35                      3.10 ± 0.36         3.02 ± 0.49            0.683                0.506         

  Concerns beliefs                  3.36 ± 0.52                      3.47 ± 0.46         3.26 ± 0.56            2.484                0.086         

  **Parents marital status**                                                                                                                       

                                    Divorced                         6                   4                      3                    1.911         0.385

                                    Non-divorced                     67                  44                     80                                 

  **Caregiver**                                                                                                                                    

                                    Parents                          70(37.6%)           39(21.0%)              77(41.4%)            7.382         0.026

                                    Non-parents                      3(16.7%)            9(50.0%)               6(33.3%)                           

  **Caregivers\' age**                                                                                                                             

                                    \<50 years                       71(37.8%)           40(21.3%)              77(40.9%)            7.5           0.024

                                    ≥50 years                        2(12.5%)            8(50.0%)               6(37.5%)                           

  **Education level**                                                                                                                              

                                    Below high school                19(29.7%)           24(37.5%)              21(32.8%)            10.125        0.006

                                    High school or above             54(38.6%)           24(17.1%)              62(44.3%)                          

  **Place of residence**                                                                                                                           

                                    Rural                            5(15.2%)            11(33.3%)              17(51.5%)            7.426         0.024

                                    Non-rural                        68(39.8%)           37(21.6%)              66(38.6%)                          

  **Total household income/year**                                                                                                                  

                                    ≤ 12,000 yuan                    26                  17                     30                   0.008         0.996

                                    \>12,000 yuan                    47                  31                     53                                 

  **Medical expenses payment**                                                                                                                     

                                    Difficult to pay                 0                   2                      2                    3.894         0.143

                                    Able to pay                      73                  46                     81                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------

Adherence Rates
---------------

Of the 204 patients, 40.7% (83/204) had high medication adherence (scores of 8), 23.5% (48/204) had medium adherence (6.82 ± 0.11), and 35.8% (73/204) had low adherence (2.76 ± 2.52).

Factors Associated With Adherence ([Tables 2](#T2){ref-type="table"}, [3](#T3){ref-type="table"})
-------------------------------------------------------------------------------------------------

### Patient-Related Factors

The univariate analysis identified two patient-related factors that were significantly associated with adherence. These were age of patient (*F* = 3.066, *P* = 0.049) and quality of life (*F* = 4.615, *P* = 0.011).

###### 

Ordered Logistic regression analysis of influencing factors of medication adherence in patients with TDs.

                       **Variable**        **B**    **SE**   **Wald**   **P**   **OR**   **95% CI**
  -------------------- ------------------- -------- -------- ---------- ------- -------- --------------
  Age                                      −0.031   0.055    0.319      0.572   0.969    0.871--1.079
  Quality of life                          0.027    0.012    4.913      0.027   1.027    1.003--1.051
  Caregiver            Parents             0.453    0.820    0.305      0.581   1.573    0.315--7.854
                       Non-parents                                                       
  Caregivers\' age     \<50 years          −0.994   0.862    1.329      0.249   0.370    0.068−2.006
                       ≥50 years                                                         
  Education level      Below high school   −0.227   0.339    0.450      0.502   0.797    0.410--1.548
                       Below high school                                                 
  Place of residence   Rural               0.859    0.404    4.519      0.034   2.361    1.069--5.212
                       Non-rural                                                         

### Medication-Related Factors

The univariate analysis found no medication-related factors associated with adherence.

### Family-Related Factors

The univariate analysis found four caregiver-related factors associated with adherence. These were the relationship between caregiver and child (χ^2^ = 7.382, *P* = 0.026), caregiver\'s age (χ^2^ = 10.125, *P* = 0.006), education level (χ^2^ = 10.125, *P* = 0.006), and place of residence (χ^2^ = 7.426, *P* = 0.024).

The six significant factors from the univariate analysis were included in the multivariate logistic regression model. The results showed that quality of life and place of residence were associated with adherence. Increasing quality of life (odds ratio \[OR\] = 1.027, 95% confidence interval \[CI\] 1.003--1.051) was associated with high adherence, and living in non-rural areas (OR = 2.361, 95% CI 1.069--5.212) was more likely to be associated with low adherence.

Discussion {#s4}
==========

Statement of Main Findings
--------------------------

This study is the first of which we are aware to use a self-reported questionnaire to assess adherence to medication in children with TDs. The results showed that only 40.7% of patients with TDs were adhering to medication guidelines. We also found that quality of life and place of residence were associated with adherence. This may be because patients with a higher quality of life have a more positive attitude to TDs and are more inclined to follow the doctor\'s advice. Children living in rural areas may be more compliant because it is inconvenient to seek medical treatment, so it is valued more. Their overall economic situation is also relatively low, so again, they are more inclined to value medication and use it correctly.

There have been no other studies assessing adherence to medication in children with TDs, so we could not compare our findings. However, a systematic review that evaluated medication adherence among children with epilepsy found that over half of patients worldwide adhered to medication guidelines when using an objective method to assess adherence, which is similar to our finding, but the pooled adherence rate for children assessed by subjective methods was 73%, which is higher than our finding ([@B13]). Compared with the adherence to treatment for asthma management, our finding is also similar to the population-based cohort study conducted in a Dutch primary care database containing medical records of 176,516 children aged 5--18 years. The authors used the medication possession ratio (MPR) to evaluate adherence and reported good adherence (MPR \> 0.8) in almost 46% of the leukotriene receptor antagonist users and in 34% of those using a fixed combination of inhaled corticosteroids and long-acting ß2-agonists ([@B14]). Another study reported the overall adherence rate to 6- Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia as 80.8% ([@B15]), which was higher than our finding. This may be because the disease was very serious, so parents attached great importance to the disease, and so the overall adherence rate was high. Our results showed that low medication adherence in children with TDs from western China is a prevalent problem.

Adherence to medication is important for effective disease management, so clinicians should try to improve it using a variety of interventions such as the following. (1) Clinicians should focus on quality of life and place of residence for patients when prescribing medicines for TDs, especially for patients with low adherence, because if they are not achieving good tic symptom control, this will aggravate the severity of the disease and affect the prognosis. It is therefore necessary to provide health education to guardians and caregivers to help them understand the condition, etiology, treatment, and precautions to take. (2) Clinicians should establish a follow-up system to detect patient medication compliance. (3) New forms of interventions and interactions, including text messaging, application-based interventions, and WeChat use, should be encouraged.

This study had some limitations. In particular, the limited sample size means that larger, multisite studies of medication adherence in children with TDs are needed to confirm these conclusions. Future prospective research should be designed with longer study periods and larger samples in naturalistic settings. It would also be helpful to examine the effectiveness of pharmacist-led intervention in improving medication adherence and to explore various forms of patient education. Future research may also use information technology, wearable devices, and other technologies to examine medication compliance.

The limitations of this study also need to be considered when interpreting its findings. First, there is no standardized tool for adherence measurement in patients with TDs. The Morisky scale is widely used and has good reliability and validity, but it is a self-reported measure that may therefore overestimate the prevalence of medication adherence. It is therefore necessary to use other objective methods to confirm these results. Second, selection bias might have occurred, because those who agreed to participate are likely to be more actively engaged with their condition and will therefore typically care more about their health. This may lead to a higher level of adherence. Third, the cross-sectional study design carries limited possibilities for exploring causal relationships and does not provide clinical follow-up. Further studies are needed to overcome these shortcomings.

Conclusion {#s5}
==========

Low medication adherence is a prevalent problem in children with TDs. Primary healthcare providers in pediatric clinics should focus on medication adherence counseling for children with TDs with a lower quality of life and who live in non-rural areas.
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